Corpus Intelligence IC Memo — INSIGHTS HOSPITAL AND MEDICAL CENTER 2026-04-26 15:55 UTC
IC Memo — INSIGHTS HOSPITAL AND MEDICAL CENTER
Investment Committee Memorandum | IL | 52 beds | Grade D | EBITDA uplift $3.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

INSIGHTS HOSPITAL AND MEDICAL CENTER

CCN 140158 | COOK, IL | 52 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

INSIGHTS HOSPITAL AND MEDICAL CENTER is a 52-bed under-performing / distressed in COOK, IL with $40.1M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 29.6% Medicare, 8.5% Medicaid, and 61.8% commercial.

Thesis: Turnaround. Our ML models identify $3.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -148.7% (+736bps).

Net Revenue HCRIS$40.1M
Current EBITDA COMPUTED$-62.6M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS32.3%
Revenue / Bed COMPUTED$771K
Net-to-Gross HCRIS81.8%
Distress Probability ML59.6%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
44
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of -100.0% places it below the state median. Among 44 size-comparable peers (26-104 beds), the median margin is -5.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (26-104), prioritizing same-state peers. 44 hospitals in the comp set.

HospitalStateBedsRevenueMargin
INSIGHTS HOSPITAL AND MEDICAL (Target)IL52$40.1M-100.0%
MIDWESTERN REGIONAL MEDICAL CEIL73$1.38B80.5%
SARAH BUSH LINCOLN HEALTH CENTIL100$448.6M-18.1%
KISHWAUKEE COMMUNITY HOSPITALIL98$355.3M25.5%
CGH MEDICAL CENTERIL95$247.1M-7.6%
MORRIS HOSPITALIL89$210.8M1.7%
HERRIN HOSPITALIL85$198.4M20.2%
FHN MEMORIAL HOSPITALIL100$149.3M3.6%
OTTAWA REGIONAL HOSPITAL & HEAIL97$147.1M18.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$842K+210bp18mo
Cost to Collect4.5%2.5%$802K+200bp12mo
Denial Rate Reduction12.0%6.5%$794K+198bp12mo
A/R Days Reduction5200.0%3800.0%$488K+122bp9mo
Clean Claim Rate88.0%96.0%$26K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$842K
Cost to Collect
$802K
Denial Rate Reduction
$794K
A/R Days Reduction
$488K
Clean Claim Rate
$26K
Total EBITDA Uplift$3.0M
Current EBITDA$-62.6M
+ RCM Uplift+$3.0M
Pro Forma EBITDA$-59.6M
Current Margin-100.0%
Pro Forma Margin-148.7%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-96.2M$-383.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-96.2M$-452.7M0.00x-100.0%
Bull Case9.0x11.0x$-86.6M$-474.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-86.6M$-542.9M0.00x-100.0%
Bear Case11.0x10.0x$-105.9M$-366.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-105.9M$-437.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 32.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 59.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 44 hospitals with 26-104 beds
  • Same-state prioritization (n=45)
  • Comp margins: P25=-16.5% / P50=-5.4% / P75=14.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.